Atul Kumar Sahu, Raja Narayanan. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Antibodies, Monoclonal/administration & dosageAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal, HumanizedDrug Therapy, CombinationFluorescein AngiographyGlucocorticoids/administration & dosageGlucocorticoids/adverse effectsHemangioma/drug therapyHemangioma/pathologyHemangioma/physiopathologyHumansInjectionsPhotochemotherapy/adverse effectsRanibizumabRetina/drug effectsRetina/pathologyRetinal Neoplasms/drug therapyRetinal Neoplasms/pathologyRetinal Neoplasms/physiopathologyTime FactorsTreatment OutcomeTriamcinolone/administration & dosageTriamcinolone/adverse effectsVisual Acuity/drug effectsVitreous Body
Substances： See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedGlucocorticoidsTriamcinoloneRanibizumab
Year: 2010 PMID： 20531149 DOI： 10.1097/IAE.0b013e3181dde596
Source DB: PubMed Journal: Retina ISSN： 0275-004X Impact factor: 4.256